SICUR 2026 Brokerage Event - Cluster 3

24–26 Feb 2026 | Madrid, Spain

PartnershipUpdated on 19 January 2026

Strategic Partnership for Emergency Hemostasis Solutions

CEO at Genexica Biotech

Menidi Aetolias-Akarnanias, Greece

About

We are seeking strategic partnerships with organisations active in civil protection, emergency response, medical technologies and security innovation to collaborate on the development and deployment of an advanced rapid hemostasis gel barrier.

The partnership aims to support co-development, validation, field testing and integration of the solution into emergency response systems and disaster preparedness frameworks.

Ideal partners include civil protection authorities, emergency services, research centres, industrial partners and system integrators interested in strengthening bleeding control capabilities in disaster-resilient society applications.

Through partnership, we aim to combine complementary expertise in biotechnology, operational requirements and deployment environments, contributing to impactful solutions aligned with Horizon Europe Cluster 3 priorities.

Looking for

  • Research and development
  • Innovation
  • Manufacturing
  • Other

Organisation

Genexica Biotech

Company

Menidi Aetolias-Akarnanias, Greece

Similar opportunities